Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06581263 · ClinicalTrials.gov registry record
Psychedelic Virtual Reality
A clinical trial of Healthy Volunteer and Virtual Reality, sponsored by Yale University.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT06581263: Recruiting study of Healthy Volunteer and Virtual Reality, sponsored by Yale University.
NCT06581263 is a study of Healthy Volunteer and Virtual Reality that is actively recruiting participants, run by Yale University. The registered enrollment target is 15 participants, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06581263, a study of Healthy Volunteer and Virtual Reality, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a novel VRP.
Primary Outcome
Subject experience will be assessed using the Altered States of Consciousness Rating Scale.
Conditions Studied
Interventions
- DEVICE Meta Quest 3
Study Locations (1)
Connecticut
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2026-03-22 |
What NCT06581263 shows while recruiting
NCT06581263 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which Meta Quest 3 is the first listed.
NCT06581263 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06581263 about?
NCT06581263 is a clinical study titled "Psychedelic Virtual Reality". The purpose of this study is to evaluate a novel VRP.
What is the current status of trial NCT06581263?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-07-22. Estimated completion is 2026-03-22.
What conditions does trial NCT06581263 study?
This clinical trial studies the following conditions: Healthy Volunteer, Virtual Reality, Psychedelic Experiences.
What interventions are being tested in trial NCT06581263?
The interventions under investigation include: Meta Quest 3 (DEVICE).
Who is sponsoring clinical trial NCT06581263?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06581263 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06581263's enrollment target sits among peer trials
15 101st of 112 higher than 10 of 112 other Healthy Volunteer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI